glp 1 agonist gastric emptying GLP-1 and Anesthesia: Considerations and Cautions for CRNAs GLP-1 Intolerance and Endoscopic Sleeve

Participants lost 16.7% of baseline weight over 64 weeks, matching clinical trial outcomes despite using half the typical drug dose

it reduces the intrinsic desire to eat, a powerful combination that forms the basis of its success as a weight-loss therapy

Vesterinen T et al

An optogenetic stimulation of GLP-1Rs in habenular circuits was also shown to abolish nicotine reward and decrease nicotine intake in mice 109

WHERE TO PLAY NEXT: MOST ATTRACTIVE GROWTH OPPORTUNITIES Where the Best Expansion Logic Sits Most Attractive Product Niches Most Attractive Customer Segments White Spaces and Unsaturated Opportunities High-Margin and Underpenetrated Pockets Most Promising Product Adjacencies 14

Mansur SA, Mieczkowska A, Flatt PR, Chappard D, Irwin N, Mabilleau G